October 13, 2021
Video
The retina field is equipped with ideal therapy and research informing implementation. Now it needs greater patient buy-in.
Article
Assessment from a patient survey showed an association between increased rates of injection treatment and increased restriction on usual activity for patients.
Rishi P. Singh, MD, discusses new VISTA/VIVID data showing what really influences a patients' likelihood and time to DME resolution when treated with aflibercept.
October 12, 2021
Theodore Leng, MD, MS, defines the trends of patient discontinuation, and how direct caregivers may help to reduce risk of losing patients.
Arshad Khanani, MD, MA, explains how new measures made available to ophthalmology will help address a quickly growing patient population.
October 11, 2021
Veeral S. Sheth, MD, MBA, discusses what ophthalmologists will need to learn about PDS application for patients with AMD.
Theodore Leng, MD, MS, discusses new findings based on IRIS registry data showing long-term discontinuation trends in patients.
An approval may be pending for the unique delivery system. An expert explains its benefit for nAMD patients and physicians alike.
A retina care team highlighted positive patient feedback from their makeshift system; could it be a long-term solution?
October 10, 2021
A greater rate of intravitreal injection appointments were delayed last year, causing worse patient scores in BCVA and OTC.
Carla Lamb, MD: Innovations in CT Scan Accuracy
Tapinarof Cream Benefits Psoriasis Regardless of Baseline Disease Severity, Duration
Philip Mease, MD: Guselkumab Addresses the Complexities of Treating Psoriatic Arthritis
